These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 11367447)

  • 1. Antiviral drug reduces shedding of herpes virus.
    Newsline People AIDS Coalit N Y; 1998 Feb; ():36. PubMed ID: 11367447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Famciclovir for the suppression of symptomatic and asymptomatic herpes simplex virus reactivation in HIV-infected persons. A double-blind, placebo-controlled trial.
    Schacker T; Hu HL; Koelle DM; Zeh J; Saltzman R; Boon R; Shaughnessy M; Barnum G; Corey L
    Ann Intern Med; 1998 Jan; 128(1):21-8. PubMed ID: 9424977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Famciclovir reduces viral mucosal shedding in HSV-seropositive persons.
    Leone P; Warren T; Hamed K; Fife K; Wald A
    Sex Transm Dis; 2007 Nov; 34(11):900-7. PubMed ID: 17538513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Famciclovir suppression of asymptomatic and symptomatic recurrent anogenital herpes simplex virus shedding in women: a randomized, double-blind, double-dummy, placebo-controlled, parallel-group, single-center trial.
    Sacks SL
    J Infect Dis; 2004 Apr; 189(8):1341-7. PubMed ID: 15073669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug effective against herpes.
    AIDS Alert; 1996 Apr; 11(4):48. PubMed ID: 11363406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of famciclovir for treating mucocutaneous herpes simplex infection in HIV-infected individuals. Collaborative Famciclovir HIV Study Group.
    Romanowski B; Aoki FY; Martel AY; Lavender EA; Parsons JE; Saltzman RL
    AIDS; 2000 Jun; 14(9):1211-7. PubMed ID: 10894286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDA approves fomivirsen, famciclovir, and Thalidomide. Food and Drug Administration.
    Highleyman L
    BETA; 1998 Oct; ():5. PubMed ID: 11365993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of herpes simplex and varicella-zoster virus infections.
    Erlich KS
    West J Med; 1997 Mar; 166(3):211-5. PubMed ID: 9143202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valuable clinical tips from recent medical meetings.
    Prescott LM
    Body Posit; 1999 Feb; 12(2):13-4. PubMed ID: 11366166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Famciclovir safe and effective for herpes.
    AIDS Patient Care STDS; 1997 Oct; 11(5):375. PubMed ID: 11361826
    [No Abstract]   [Full Text] [Related]  

  • 11. Patient-initiated, twice-daily oral famciclovir for early recurrent genital herpes. A randomized, double-blind multicenter trial. Canadian Famciclovir Study Group.
    Sacks SL; Aoki FY; Diaz-Mitoma F; Sellors J; Shafran SD
    JAMA; 1996 Jul; 276(1):44-9. PubMed ID: 8667538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-day versus 5-day famciclovir as treatment of recurrences of genital herpes: results of the FaST study.
    Bodsworth N; Bloch M; McNulty A; Denham I; Doong N; Trottier S; Adena M; Bonney MA; Agnew J;
    Sex Health; 2008 Sep; 5(3):219-25. PubMed ID: 18771636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Famciclovir safe and effective for management of shingles.
    AIDS Patient Care STDS; 1997 Jun; 11(3):198. PubMed ID: 11361804
    [No Abstract]   [Full Text] [Related]  

  • 14. Famvir effective in suppressing recurrent genital herpes.
    AIDS Patient Care STDS; 1998 Dec; 12(12):944. PubMed ID: 11362073
    [No Abstract]   [Full Text] [Related]  

  • 15. [The efficiency of combined therapy of herpes virus infection in HIV infected patients].
    Papuashvili MN; Shchelkanov MIu
    Vopr Virusol; 2004; 49(2):25-9. PubMed ID: 15106380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antivirals for herpes simplex viruses.
    Sawleshwarkar S; Dwyer DE
    BMJ; 2015 Jul; 351():h3350. PubMed ID: 26160487
    [No Abstract]   [Full Text] [Related]  

  • 17. The comparative effects of famciclovir and valacyclovir on herpes simplex virus type 1 infection, latency, and reactivation in mice.
    LeBlanc RA; Pesnicak L; Godleski M; Straus SE
    J Infect Dis; 1999 Sep; 180(3):594-9. PubMed ID: 10438344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes.
    Sperling RS; Fife KH; Warren TJ; Dix LP; Brennan CA
    Sex Transm Dis; 2008 Mar; 35(3):286-90. PubMed ID: 18157071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Herpes simplex].
    Välimaa H; Seppänen M; Hukkanen V
    Duodecim; 2013; 129(1):31-40. PubMed ID: 23431880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpes simplex virus type 2 (HSV-2) genital shedding in HSV-2-/HIV-1-co-infected women receiving effective combination antiretroviral therapy.
    Péré H; Rascanu A; LeGoff J; Matta M; Bois F; Lortholary O; Leroy V; Launay O; Bélec L;
    Int J STD AIDS; 2016 Mar; 27(3):178-85. PubMed ID: 25769886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.